Keep CAALM and Carry On Doing Clinical Trials

Keep CAALM and Carry On Doing Clinical Trials

 Enabling excellence in clinical trial research services through collaborative working Frontier Science Scotland prides itself on its collaborative working approach to providing clinical research services to our international clients that has been proven to yield...
Frontier Science Scotland Strengthens Board of Trustees

Frontier Science Scotland Strengthens Board of Trustees

Kincraig, Scotland, 17 June 2024 – Frontier Science Scotland (FSS), a leading contract clinical research organisation, advancing drug development by delivering excellence in clinical trials, announces the appointment of Professor Bjoern Schelter as a new Director to...
Spotlight on NordICC for Colorectal Cancer Awareness Month

Spotlight on NordICC for Colorectal Cancer Awareness Month

March is Colorectal Cancer (CRC) Awareness Month, raising awareness of the second most common type of cancer, which accounts for 10% of all cancer cases worldwide. By 2030, CRC – also known as bowel cancer – will be the biggest threat to life for people aged 50 and...
Cardiac Safety in the APHINITY trial

Cardiac Safety in the APHINITY trial

OVERVIEW ESMO Open has published an article co-authored by a member of our Biostatistics team. Results of the exploratory analysis conclude that after >6 years of median follow-up, pertuzumab and trastuzumab did not increase cardiotoxicity risk compared to...